Establishment and Characterization of Dedifferentiated Chondrosarcoma Cell Line and Effect of Mutant IDH1 inhibitor

被引：0
|
作者：
Saisuwan, Krittamate [1 ]
Seiji, Okada [2 ]
Boonnate, Piyanard [3 ]
Rumi, Nakagawa [4 ]
Tohru, Hirozane [1 ]
Kazutaka, Kikuta [1 ]
机构：
[1] Tochigi Canc Ctr, Div Musculoskeletal Oncol Orthopaed Surg, Utsunomiya, Tochigi, Japan
[2] Kumamoto Univ, Div Hematopoiesis, Kumamoto, Japan
[3] Chulabhorn Res Inst, Lab Environm & Toxicol, Bangkok, Thailand
[4] Tochigi Canc Ctr, Div Diagnost Patho, Utsunomiya, Tochigi, Japan
来源：
CANCER SCIENCE | 2025年 / 116卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
P-3099
引用
收藏
页码：1628 / 1628
页数：1
相关论文
共 50 条
  • [1] Establishment and characterization of a novel dedifferentiated chondrosarcoma cell line, SMU-DDCS, harboring an IDH1 mutation
    Makoto Emori
    Naoya Nakahashi
    Akira Takasawa
    Kenji Murata
    Yasutaka Murahashi
    Junya Shimizu
    Tomohide Tsukahara
    Shintaro Sugita
    Kohichi Takada
    Tadashi Hasegawa
    Makoto Osanai
    Kosuke Iba
    Human Cell, 2023, 36 : 2195 - 2203
  • [2] Establishment and characterization of a novel dedifferentiated chondrosarcoma cell line, SMU-DDCS, harboring an IDH1 mutation
    Emori, Makoto
    Nakahashi, Naoya
    Takasawa, Akira
    Murata, Kenji
    Murahashi, Yasutaka
    Shimizu, Junya
    Tsukahara, Tomohide
    Sugita, Shintaro
    Takada, Kohichi
    Hasegawa, Tadashi
    Osanai, Makoto
    Iba, Kosuke
    HUMAN CELL, 2023, 36 (06) : 2195 - 2203
  • [3] Mutant IDH1 is essential for chondrosarcoma growth
    Li, Luyuan
    Hu, Xiaoyu
    Eid, Josiane E.
    DeSalvo, Joanna
    Trent, Jonathan C.
    CANCER RESEARCH, 2019, 79 (13)
  • [4] IDH1/2 Mutational Testing for the Diagnosis of Conventional and Dedifferentiated Chondrosarcoma
    Chen, Shaoxiong
    Wei, Shi
    Post, Kristin
    Curless, Kendra
    Hattab, Eyas
    Cheng, Liang
    LABORATORY INVESTIGATION, 2015, 95 : 15A - 16A
  • [5] IDH1/2 Mutational Testing for the Diagnosis of Conventional and Dedifferentiated Chondrosarcoma
    Chen, Shaoxiong
    Wei, Shi
    Post, Kristin
    Curless, Kendra
    Hattab, Eyas
    Cheng, Liang
    MODERN PATHOLOGY, 2015, 28 : 15A - 16A
  • [6] Characterization of IDH1/IDH2 Mutation and D-2-Hydroxyglutarate Oncometabolite Level in Dedifferentiated Chondrosarcoma
    Mohammad, Nissreen
    Lum, Amy
    Lin, Jonah
    Wong, Derek
    Ho, Julie
    Lee, Cheng-Han
    Ng, Tony
    Yip, Stephen
    MODERN PATHOLOGY, 2018, 31 : 34 - 34
  • [7] Characterization of IDH1/IDH2 Mutation and D-2-Hydroxyglutarate Oncometabolite Level in Dedifferentiated Chondrosarcoma
    Mohammad, Nissreen
    Lum, Amy
    Lin, Jonah
    Wong, Derek
    Ho, Julie
    Lee, Cheng-Han
    Ng, Tony
    Yip, Stephen
    LABORATORY INVESTIGATION, 2018, 98 : 34 - 34
  • [8] Establishment and Characterization of a Novel Dedifferentiated Chondrosarcoma Cell Line DDCS2
    Li, Xiaoyang
    Dean, Dylan C.
    Ferreira, Al
    Nelson, Scott D.
    Hornicek, Francis J.
    Yu, Shengji
    Duan, Zhenfeng
    CANCER CONTROL, 2021, 28
  • [9] Establishment and characterization of a novel dedifferentiated chondrosarcoma cell line, NCC-dCS1-C1
    Rieko Oyama
    Fusako Kito
    Mami Takahashi
    Marimu Sakumoto
    Kumiko Shiozawa
    Zhiwei Qiao
    Rei Noguchi
    Takashi Kubo
    Shunichi Toki
    Fumihiko Nakatani
    Akihiko Yoshida
    Akira Kawai
    Tadashi Kondo
    Human Cell, 2019, 32 : 202 - 213
  • [10] Establishment and characterization of a novel dedifferentiated chondrosarcoma cell line, NCC-dCS1-C1
    Oyama, Rieko
    Kito, Fusako
    Takahashi, Mami
    Sakumoto, Marimu
    Shiozawa, Kumiko
    Qiao, Zhiwei
    Noguchi, Rei
    Kubo, Takashi
    Toki, Shunichi
    Nakatani, Fumihiko
    Yoshida, Akihiko
    Kawai, Akira
    Kondo, Tadashi
    HUMAN CELL, 2019, 32 (02) : 202 - 213
12345